| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |